Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Technology ; By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-Based Multiplex Assays); By Application, By End-User; By Regions; Segment Forecast, 2022 - 2030
The global multiplex assays market size is expected t-reach USD 5.57 billion by 2030, according t-a new study by Polaris Market Research. The report “Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Technology; By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-Based Multiplex Assays); By Application, By End-User; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.
The key factors driving the market’s growth include adopting multiplex assays across various verticals such as health services and others. Due t-the growing use of customized treatment and benefits over standard tests, the market is expected t-rise rapidly. Medical science, which has gained popularity in recent years, strives t-provide individual patients with tailored therapies based on the molecular foundation of their disease.
Based on the type, the nucleic acid segment accounted for the leading share in the industry in 2021. This is due t-the rising use of nucleic acids, ease of configuration t-detect practically any target, low sample volume requirements, and level of automation t-be achieved. A rise in the use of molecular diagnostic tests developed t-diagnose diseases, such as human genetic markers, such as cancer, and genetic markers for disease predisposition als-contributes t-the economic development of the nucleic acid-based segment.
Market players such as Luminex Corporation, Enz-Life Sciences, Inc.,Promega Corporation, Mes-Scale Diagnostics, Quanterix, Therm-Fisher Scientific Inc., Qiagen N.V., Illumina, Inc, Shimadzu Biotech,Abcam plc, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Randox Laboratories, Merck KGaA, Agilent Technologies, Inc., Olink, DiaSorin S.p.A., Antigenix America, Inc., Siemens Healthineers, PerkinElmer, Inc., Boster Biological Technology, Seegene, and Cayman Chemical Company are some key players operating in the global market.
In August 2021, The BD COR System, a new automated diagnostic system from Becton, Dickinson, and Company, was released. In centralized laboratories across the U.S., the system uses robots and sample management software algorithms for genetic disease testing. Thus, the development of new technologies by major players and adoption of them across various laboratories is boosting the market growth during the forecast period.
Polaris Market Research has segmented the multiplex assays market report based on type, technology, application, end-user, and region:
Multiplex assays, Type Outlook (Revenue – USD Billion, 2018 – 2030)
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook